Sulpiride for schizophrenia-Reference-Cited by-同舟云学术

Sulpiride for schizophrenia

Published:1999-01-25 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Soares Bernardo GO¹,Fenton Mark²,Chue Pierre³

Affiliation:

1. Universidade Federal de São Paulo; Brazilian Cochrane Centre; Rua Pedro de Toledo 598 São Paulo São Paulo Brazil 04039-001

2. National Institute for Health and Clinical Excellence; Database of Uncertainties about the Effects of Treatments (DUETs); Level 1A, City Tower, Piccadilly Plaza Middle Way Manchester UK M1 4BD

3. University of Alberta; Department of Psychiatry; 3rd Floor 108th Street Building 9942-108 Street Edmonton Alberta Canada T5K 2J5

Publisher

Wiley

Subject

Pharmacology (medical)

Reference117 articles.

1. Study of the clinical effects of sulpiride and perphenazine in 82 schizophrenic patients by the double blind method;Asada;Encephale,1976

2. Clinical trial with sulpiride and placebo in chronic schizophrenics study of 89 patients using the Harris-Letemendia-Willems scale;Mezquita Blanco;Archivos de Neurobiologia - Madrid,1972

3. Comparison of sulpiride and chlorpromazine in psychoses. A double-blind multicentre study;Bratfos;Acta Psychiatrica Scandinavica,1979

4. Sulpiride - an antipsychotic agent: comparative trial versus haloperidol;Cassano;Psychopharmacology Bulletin,1977

5. Sulpiride versus haloperidol in schizophrenia: a double-blind comparative trial;Cassano;Current Therapeutic Research,1975

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney disease;Frontiers in Immunology;2023-03-21

2. Enhancement of graphene oxide through β-cyclodextrin composite to sensitive analysis of an antidepressant: Sulpiride;Open Chemistry;2021-01-01

3. A Comprehensive Review on Importance and Quantitation of Atypical Antipsychotic Drugs and their Active Metabolites in Commercial Dosage Forms;Current Pharmaceutical Analysis;2020-09-28

4. MAM-E17 rat model impairments on a novel continuous performance task: effects of potential cognitive enhancing drugs;Psychopharmacology;2017-07-26

5. In Vivo Systems Response Profiling and Multivariate Classification of CNS Active Compounds: A Structured Tool for CNS Drug Discovery;ACS Chemical Neuroscience;2017-01-09